| 388.5 0 (0%) | 11-17 09:37 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 379.93 | 1-year : | 420.63 |
| Resists | First : | 325.28 | Second : | 360.13 |
| Pivot price | 313.15  |
|||
| Supports | First : | 268.91 | Second : | 223.73 |
| MAs | MA(5) : | 288.95 |
MA(20) : | 321.23 |
| MA(100) : | 322.17 |
MA(250) : | 349.7 |
|
| MACD | MACD : | -13.1 |
Signal : | -7.6 |
| %K %D | K(14,3) : | 9.8 |
D(3) : | 5.7 |
| RSI | RSI(14): 25 |
|||
| 52-week | High : | 473.5 | Low : | 261.58 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ BIO ] has closed above bottom band by 8.0%. Bollinger Bands are 196.4% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 9 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 287.13 - 289.89 | 289.89 - 291.55 |
| Low: | 270.4 - 273.99 | 273.99 - 276.17 |
| Close: | 275.61 - 281.46 | 281.46 - 285 |
Tue, 16 Apr 2024
Closing Bell: Universal Ibogaine Inc flat on Friday (IBO) - The Globe and Mail
Sat, 30 Mar 2024
Highlights! Ibo Aslan scores one-punch revenge knockout on former foe Anton Turkalj in UFC debut | UFC Atlantic City ... - MMA Mania
Sat, 30 Mar 2024
UFC Atlantic City video: Ibo Aslan demolishes Anton Turkalj after wild slugfest - MMA Fighting
Sat, 30 Mar 2024
UFC on ESPN 54 Highlight Video: Ibo Aslan Levels Anton Turkalj - Sherdog.com
Sat, 30 Mar 2024
Ibo Aslan - UFC
Mon, 25 Mar 2024
Ibo Aslan vs Anton Turkalj Pick, 3/30/2024 Predictions UFC Atlantic City Odds - Doc's Sports
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NYSE
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 23 (M) |
| Shares Float | 20 (M) |
| Held by Insiders | 15.2 (%) |
| Held by Institutions | 81.6 (%) |
| Shares Short | 565 (K) |
| Shares Short P.Month | 503 (K) |
| EPS | -21.81 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 306.51 |
| Profit Margin | -23.9 % |
| Operating Margin | 14.2 % |
| Return on Assets (ttm) | 1.7 % |
| Return on Equity (ttm) | -7 % |
| Qtrly Rev. Growth | -6.7 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 114 |
| EBITDA (p.s.) | 21.84 |
| Qtrly Earnings Growth | -56.3 % |
| Operating Cash Flow | 375 (M) |
| Levered Free Cash Flow | 171 (M) |
| PE Ratio | -12.83 |
| PEG Ratio | 1.6 |
| Price to Book value | 0.91 |
| Price to Sales | 2.45 |
| Price to Cash Flow | 17.47 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|